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Background: The generation of evidence is integral to the work of public health and health service providers.
Traditionally, ethics has been addressed differently in research projects, compared with other forms of evidence
generation, such as quality improvement, program evaluation, and surveillance, with review of non-research
activities falling outside the purview of the research ethics board. However, the boundaries between research and these
other evaluative activities are not distinct. Efforts to delineate a boundary – whether on grounds of primary purpose,
temporality, underlying legal authority, departure from usual practice, or direct benefits to participants – have been
unsatisfactory.
Public Health Ontario has eschewed this distinction between research and other evaluative activities, choosing to
adopt a common framework and process to guide ethical reflection on all public health evaluative projects throughout
their lifecycle – from initial planning through to knowledge exchange.
Discussion: The Public Health Ontario framework was developed by a working group of public health and ethics
professionals and scholars, in consultation with individuals representing a wide range of public health roles. The first
part of the framework interprets the existing Canadian research ethics policy statement (commonly known as the TCPS
2) through a public health lens. The second part consists of ten questions that guide the investigator in the application
of the core ethical principles to public health initiatives.
The framework is intended for use by those designing and executing public health evaluations, as well as those
charged with ethics review of projects. The goal is to move toward a culture of ethical integrity among investigators,
reviewers and decision-makers, rather than mere compliance with rules. The framework is consonant with the
perspective of the learning organization and is generalizable to other public health organizations, to health services
organizations, and beyond.
Summary: Public Health Ontario has developed an ethics framework that is applicable to any evidence-generating
activity, regardless of whether it is labelled research. While developed in a public health context, it is readily adaptable
to other health services organizations and beyond.
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The practice of public health involves both the generation
and use of a wide variety of evidence for decision-making.
Evaluation routinely accompanies the introduction of new
public health programs and services or the modification of
established programs. Surveillance programs monitor in-
dicators of health status as well as social and environ-
mental conditions that may affect public health. Quality
improvement activities collect data to ensure that ongoing
programs and services are being implemented to ap-
propriate standards. Research serves to address broader
knowledge gaps to inform all of these activities.
Traditionally, ethics has been addressed differently in re-
search projects, as compared with quality improvement,
program evaluation, and surveillance, with only research
requiring formal review by a research ethics board (REB).
However, all these initiatives involve the systematic collec-
tion of data about individuals, their communities, their
environments, and the health and social services they re-
ceive. They require either the primary collection of new
data or the use of existing data for these purposes. They
frequently use common methods and pose common risks
to participants. Ethical issues may arise at any point in the
conduct of any of these activities. Otto and colleagues
point out that distinguishing between research and public
health practice is particularly challenging, as public health
practice may include hypothesis testing and use of the
same epidemiologic study design, sampling and analysis
techniques as a research project [1]. While not necessarily
intended, public health practice may also lead to gene-
ralizable knowledge and be published [1].
There is general agreement that some form of ethical
reflection or review is important for all types of evidence-
generating initiatives, whether or not they constitute for-
mal research [2-6]. It is widely suggested that review of
non-research activities falls outside the purview of the REB
[2,5,7,8]. However, the establishment of separate review
processes for research and other types of evidence-genera-
ting initiatives is problematic because it requires one to dif-
ferentiate between research and these other non-research
initiatives. Efforts to delineate such a boundary [3,4,9,10] –
whether on grounds of primary purpose (generalizable
knowledge), temporality (turn-around time from evidence
to action), underlying legal authority, departure from usual
practice, or direct benefits to participants – have been
unsatisfactory.
The wisdom of maintaining this artificial division bet-
ween research and other evaluative activities has been
debated in a number of circles in recent years. Fairchild
and Bayer [11] note:
The recent efforts to provide definitional solutions to
the question of research and public health practice
involve twists and turns that inevitably produceresults that are riddled with inconsistencies and that
are conceptually unsatisfying.
In the context of clinical care and research, Kass and
colleagues have systematically delineated the conceptual,
moral, and empirical problems with attempting to draw a
sharp distinction between clinical research and practice,
with a view to taking a more holistic approach [12].
In summary, there is a growing recognition that the dis-
tinction between research and other evidence-generating
activities is artificial and selective ethics review of activities
labeled “research” is problematic. With this in mind, we
sought to develop a common ethics framework for all
evidence-generating activities, regardless of the label.
Discussion
The context
Public Health Ontario (PHO) is a government agency
charged with the protection and promotion of health
and the reduction of health inequities for Ontarians
[13]. Through legislation, it operates as a separate entity
from the government but within a broader accounta-
bility framework set in government directives and proce-
dures. The services offered by PHO are broad in nature
and include: research, program evaluation, surveillance
and population health assessment. As a new agency,
PHO had no prior policies or infrastructure to address
the ethical review of research or other evaluative acti-
vities conducted by its staff. Recognizing the challenges
with the blur between research and other evaluative
activities, we sought to adopt a holistic approach to the
ethical conduct of these initiatives. We found no litera-
ture describing any other organization that had done
this. So, with the support of our President and CEO, we
set out to develop a conceptual framework for the
ethical conduct of public health initiatives that addresses,
in an integrated fashion, research, surveillance, and other
evidence-generating activities involving humans, their data
or their biological samples, proportionate to the risk to
human participants [14]. The use of a single system avoids
the problems associated with trying to distinguish re-
search from non-research described above, and ensures
that all initiatives receive ethics assessment proportionate
to the risk.
The PHO framework was developed by a working group
of public health and ethics professionals and scholars, in
consultation with individuals representing a wide range of
public health roles. The concepts in the document were
presented at various fora and early drafts were circulated
to public health practitioners and ethicists for comment.
The resulting feedback was incorporated into the first
completed version of the framework document, which
was released broadly for discussion in June 2011 to pu-
blic health units across Ontario, independent academics
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viduals at specific organizations described in the acknow-
ledgements. These comments informed the revision of the
framework document into its current version.
Why build on a research ethics paradigm?
The framework consists of two parts. The first part in-
terprets the existing Canadian research ethics policy
statement through a public health lens. The second part
consists of ten questions that guide the investigator in
the application of the core ethical principles to public
health initiatives.
Our framework builds on the joint research ethics policy
statement of the three federal research agencies in Canada,
commonly known as the TCPS 2 [8]. All Canadian institu-
tions must agree to comply with the TCPS 2 to be eligible
to administer funds from the three federal research agen-
cies in Canada. Like many other research guidance docu-
ments, TCPS 2 has been criticised for being too strongly
driven by the biomedical research paradigm. We consi-
dered developing or adapting an ethics framework that
was specifically grounded in public health values. The de-
cision to use the TCPS 2 and its three core principles of
respect for persons, concern for welfare, and justice as the
starting point was based on a number of considerations:
– We sought to create a single process for all our
public health evaluative activities while remaining
compliant with TCPS 2 requirements for research.
– The foundational principles of TCPS 2 – respect for
persons, concern for welfare and justice – are
consonant with other internationally accepted
bioethics principles. While additional principles that
are particularly relevant to public health may also be
introduced, the three principles of the Policy serve
as the core.
– Concerns about the limitations of the TCPS 2
largely relate to misapplication. Perceived challenges
with the applicability of the TCPS 2 in many
instances reflect overly rigid interpretations amidst a
cultural bias towards individual autonomy and a
focus on avoiding risk, and not limitations in the
actual guidance provided by the TCPS 2.
Ten guiding questions
The public health lens we apply to the TCPS 2 considers
how the three core principles may be read in the context
of community or population interests, expanding the
ethical considerations to include: the relational interests
of the individual as part of a community (relational
autonomy); solidarity; social justice; and reciprocity. To
facilitate application of the three principles to specific
projects, the PHO framework poses ten guiding ques-
tions to be considered when planning and reviewingevidence-generating public health initiatives. In Table 1,
we provide a brief synopsis of the public health framing
of each of the ten questions. The full discussion may be
found elsewhere [14] It is important that the guiding
questions be considered together and that they not be
used in isolation from the discussion regarding their
interpretation and application through a public health
lens.
These questions are informed by several earlier frame-
works developed for clinical research [15], public health
[16], and health services research [2]. Many of the ques-
tions themselves do not differ from what REBs typically
address when reviewing a research protocol. The added
value we provide is the public health perspective in the
explanatory text – e.g. considering harm to commu-
nities, reciprocity, and the levelling of autonomy with
other principles.
Question ten may be the most contentious. It asks
about the potential longer-term consequences, with an
emphasis on unanticipated adverse effects of a study.
Some research guidance specifically identifies this ques-
tion as being out of scope of ethics review [17]. While
this may be reasonable in an academic setting, in the
applied world of public health one must consider the
potential implications of an evaluation on future policy.
Application of the PHO framework
The PHO framework is more than a tool for the exter-
nal review of a public health protocol. It was designed
for use by those who are developing the protocol – from
the formulation of objectives through to reporting of
the findings [18]. We believe this will assist public
health professionals in taking ownership of the ethical
issues inherent in their practice, rather than complying
with requirements imposed by an external ethics
authority. This is particularly important in emergency
situations, where action may need to be taken before
formal ethics review could take place.
We recognize that extending ethics review to all
knowledge-generating activities has major workload im-
plications for an institution’s ethics oversight process.
To address this issue, we are rolling out a number of
tools and processes to manage the increased volume of
projects that will come under scrutiny. These include:
a) a risk screening tool that creates a new
risk category for minimal risk evaluative
activities that have relatively well defined
risks and which can be reviewed by the
research ethics officer for appropriate
measures to mitigate those risks.
b) the development of standardized protocols
for certain types of routine evaluative
activities that are pre-reviewed for ethics.
Table 1 Ten guiding questions
No. Question
1 What are the objectives of the initiative? How are they linked to potential improvements in public health?
− A clear link must be provided between the initiative and potential public health improvements; potential benefits may be immediate or
future. Collection of data where public health value is more speculative may be permissible with justification.
− This question serves as an anchor for review, as many of the questions below relate back to the original objectives.
2 Can the objectives be achieved using the proposed methods?
− Initiatives lacking sufficient methodological rigour may lead to data that is of poor quality or invalid, wasting resources and potentially
causing potential harm through misinformation.
− Requirements for scientific rigour must be balanced with sensitivity to the context in which an activity is implemented.
− Judgment regarding the design of an initiative requires relevant methodological expertise as well as some knowledge about the participating
populations and other contextual details, as relevant.
3 Who are the expected beneficiaries of the knowledge gained or other benefits?
− Beneficiaries may include individuals and/or communities, whether or not they are directly participating in the proposed initiative.
− Individual and collective interests may be shared or competing, or both, depending on the circumstance.
4 What are the burdens and potential harms associated with the proposed initiative? Who bears them?
− Harms associated with evidence generation in public health frequently arise from collection, use or disclosure of information; potential
consequences include stigmatization, discrimination, psychological distress or economic loss. Other harms, such as threats to health, may
also occur.
− Burdens generally are borne by those participating in an initiative. Harms may affect individuals and/or communities, whether or not they are
directly participating in the proposed initiative.
− Potential harm to relationships should be considered.
− Where possible, an effort must be made to mitigate or minimize risks and burdens, balancing against any loss in potential benefit.
5 Are burdens and potential harms justified in light of the potential benefits to participants and/or to society?
− Burdens and potential harms should be weighed against not only potential benefit from conducting an inquiry, but the harm in not carrying
out that inquiry.
− Burdens or harms may accrue to different individuals/groups than those receiving the benefit but, where this is the case, there should be
some justification.
− “Fair procedures” such as transparency and stakeholder participation should be used to guide decision making regarding balancing of
burdens, harms and benefits.
6 Is selection of participants fair and appropriate?
− Fair distribution of burdens, risks and potential benefits includes paying special attention to vulnerable or disadvantaged populations, to be
included where there is potential benefit, excluded where certain groups face greater burden or risk, or preferentially
− Included because of increased probability or magnitude of benefit.
− The principle of reciprocity requires finding ways to give back to individuals or communities that bear a disproportionate share of burden or
risk for the benefit of others.
7 Is individual informed consent warranted? Is it feasible? Is it appropriate? Is it sufficient?
− While important, individual autonomy does not always take priority over other ethical concerns, such as welfare of populations.
− For many public health initiatives, obtaining individual consent may not be required, feasible or appropriate. Where departure from individual
informed consent is proposed, consider alternatives such as broad consent, notice with opt out, and consultation with a representative
sample of the population of interest.
− In certain cases, such as examination of illegal behaviour, alternative approaches such as use of verbal consent or pseudonyms may
be appropriate.
8 Is community engagement warranted? Is it feasible? What level of engagement is appropriate?
− Community engagement is encouraged where feasible and might be used in lieu of, or in addition to individual consent.
− Engagement may range from informing to consultation, collaboration and empowerment.
− Community engagement may include some form of collective consent or consensus process authorizing the initiative in the community.
− Challenges include determining what level of engagement is appropriate, what counts as a community, and who the appropriate
representatives are.
9 What are the social justice implications of this initiative?
− Projects that reinforce existing inequities should be avoided and opportunities to promote social justice should be considered where possible.
− Extra resources or special measures may be needed to promote social justice, for example to ensure that disadvantaged groups are
appropriately considered in the development of project objectives, or to remove barriers to their participation in public health initiatives.
10 What are the potential longer-term consequences?
− Where possible, potential negative long-term consequences of an initiative should be considered and plans for mitigating these risks should
be developed prior to implementation.
− Community engagement can be helpful both in identifying potential long term harms, and in devising methods to address them.
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papers.
Adoption of this framework by public health organiza-
tions will require training of ethics review board mem-
bers to manage the cultural shift to this framework from
the traditional model of ethics review. This shift may not
be particularly challenging, given the alignment of the
framework with widely accepted public health principles.
At PHO, we have used the framework as the basis for
reviewer assessment forms, so that the ten questions are
systematically applied to each project.
The PHO Framework in the context of other calls for
ethics reform
Our PHO framework is consonant with a recent call for
an ethics framework for the learning health care system,
which also advocates for the integration of rather than
the distinction between research and practice [19]. That
framework is structured around the obligations of mul-
tiple parties to contribute to the common purpose of im-
proving the quality and value of clinical care and health
care systems. Our framework particularly resonates with
the last three obligations: to reduce health inequalities
among populations; to conduct responsible activities that
foster learning from clinical care and clinical information;
and to contribute to the common purpose of improving
the quality and value of clinical care and health care sys-
tems. With regard to the last obligation, the authors iden-
tify an obligation of the individual patient to contribute,
under limited conditions, to learning that is integrated
with their care. Similarly, public health is founded on the
assumption that there are certain common goods that
ought to be promoted. Rather than referring to obligations
of individual patients, we have framed this in terms of the
inter-dependence among members within and between
communities and draw upon the principle of solidarity to
promote our collective welfare.
While we acknowledge that the current research over-
sight system is often too bureaucratic, we do not agree
with calls for exemption from ethics review as a class
for surveys, focus groups, and similar research involving
competent adults, as has been advocated in some circles
[20]. There may still be non-trivial risks associated with
these data collection activities – particularly in public
health, where one may be working with vulnerable popu-
lations, asking sensitive questions, or working with infor-
mation that is not in the public domain. Consequently, at
a minimum, all new evaluative studies involving human
participants must complete the risk screening tool and
undergo an initial screen by the ethics officer.
We are unaware of any published literature describing
institutions that have taken an integrated perspective
similar to that which we have put forward. Anecdotally,
as we developed our framework, we learned that severallocal public health units also review quality improve-
ment and research studies through the same process,
but they had not created a comprehensive conceptual
framework like ours. This may well be the case with
other institutions.
Summary
Public Health Ontario has developed a framework to
guide ethical reflection on all public health evaluative
projects throughout their lifecycle – from initial plan-
ning through to knowledge exchange – eschewing the
distinction between research and other evaluative acti-
vities. The framework is intended for use by those de-
signing and executing public health evaluations, and not
only for those charged with ethics review of projects.
While we have built upon the TCPS 2’s three core princi-
ples of respect for persons, concern for welfare, and justice,
we have augmented these with concepts of: relational au-
tonomy and respect for communities; the inter-relationship
of individual and community welfare; solidarity and the
common good; the positive obligation to promote social
justice; and the importance of reciprocity in circumstances
when individuals or subgroups put themselves at risk or
bear substantial burden for the benefit of others.
The use of guiding questions rather than statements of
principles or rules was chosen to help move toward a cul-
ture of ethical integrity among investigators, reviewers
and decision-makers, rather than one of compliance with
rules. We believe this to be consistent with the perspective
of the learning organization. We believe the framework
is generalizable to public health practitioners in other ju-
risdictions and, with appropriate adaptation, even beyond
public health to any discipline engaged in applied evalu-
ation of public programs and services including health ser-
vices, education, and social sciences.
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